Taladegib
- Generic Name
- Taladegib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H24F4N6O
- CAS Number
- 1258861-20-9
- Unique Ingredient Identifier
- QY8BWX1LJ5
- Background
Taladegib has been used in trials studying the treatment of Solid Tumor, COLON CANCER, BREAST CANCER, Advanced Cancer, and Rhabdomyosarcoma, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath